Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MBX/Net income

MBX Biosciences, Inc. (MBX) Net income 2024–2026

MBX Biosciences, Inc. (MBX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.

-$87.0MFY2026 · since FY2024: -$32.6M → -$87.0M
242526
Fiscal yearValueYoY
FY2026-$87.0M-40.5%
FY2025-$61.9M-90.2%
FY2024-$32.6M—

Source: SEC XBRL filings · For reference only · Not investment advice

More MBX financial trends

MBX RevenueMBX Net marginMBX Gross profitMBX Gross marginMBX Operating incomeMBX Operating marginMBX Operating cash flowMBX Free cash flowMBX Capital expendituresMBX Return on equityMBX Stock buybacksMBX Dividends paidMBX Total assetsMBX Total liabilitiesMBX Shareholders’ equityMBX overview →